Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06901375
EARLY_PHASE1

Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication

Sponsor: Nanjing First Hospital, Nanjing Medical University

View on ClinicalTrials.gov

Summary

Vonoprazan and high-dose amoxicillin dual therapy was used as a control group to evaluate the clinical efficiency and safety of Zuojin Wan combined with vonoprazan and high-dose amoxicillin dual therapy in the treatment of helicobacter pylori associated chronic gastritis,through a randomized controlled trail.

Official title: 14-day Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in the Treatment of Helicobacter Pylori Associated Chronic Gastritis:A Single-Center,Randomized Controlled Study

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

136

Start Date

2025-05

Completion Date

2025-08

Last Updated

2025-03-28

Healthy Volunteers

No

Interventions

DRUG

Vonoprazan

20 mg tablet twice daily

DRUG

Amoxicillin

1 g tablet three times daily

DRUG

Zuojin Wan

3 g tablet twice daily

Locations (1)

Nanjing First Hospitai

Nanjing, Jiangsu, China